Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;11(2):207-213.
doi: 10.1007/s13659-020-00278-6. Epub 2020 Nov 3.

Bousmekines A-E, New Alkaloids from Two Bousigonia Species: B.angustifolia and B. mekongensis

Affiliations

Bousmekines A-E, New Alkaloids from Two Bousigonia Species: B.angustifolia and B. mekongensis

Zong-Qing Huo et al. Nat Prod Bioprospect. 2021 Apr.

Abstract

Four new monoterpenoid indole alkaloids, bousmekines A-D (1-4), and one new pyranopyridine alkaloid, bousmekine E (5), were isolated from the twigs and leaves of Bousigonia angustifolia and Bousigonia mekongensis. Their structures including absolute configurations were elucidated by a combination of MS, NMR, ECD calculation, and single-crystal X-ray diffraction analysis. Compound 2 was an eburnea-type MIAs characterized by a rare chlorine atom while 5 possessed a novel pyranopyridine moiety. Their cytotoxicities against several human cancer cell lines were evaluated and compound 1 exhibited significant cytotoxicity with IC50 values of 0.8-7.4 μM.

Keywords: B. angustifolia; B. mekongensis; Bousigonia; Bousmekines A-E; Monoterpenoid indole alkaloids.

PubMed Disclaimer

Conflict of interest statement

Authors declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Structures of compounds 15
Fig. 2
Fig. 2
Key HMBC (arrow) and 1H-1H COSY (bold) correlations of compounds 15
Fig. 3
Fig. 3
Key ROESY correlations of compounds 1, 3, and 5
Fig. 4
Fig. 4
Experimental and calculated ECD of 1
Fig. 5
Fig. 5
X-ray crystal structure of 2

References

    1. P. M. Dewick, Alkaloids. In Medicinal Natural Product: A Biosynthetic Approach; John Wiley & Sons Ltd: Chichester, (2002) 340–341.
    1. Deng Y, Bao MF, Shi BB, Wu J, Cai XH. Nat. Prod. Bioprospect. 2018;8:183–188. doi: 10.1007/s13659-018-0166-x. - DOI - PMC - PubMed
    1. Li XM, Jiang XJ, Wei GZ, Ren LH, Wang LX, Cheng XL, Wang F. Nat. Prod. Bioprospect. 2019;9:424–429. doi: 10.1007/s13659-019-00226-z. - DOI - PMC - PubMed
    1. Liu JW, Huo ZQ, Zhao Q, Hao XJ, He HP, Zhang Y. Fitoterapia. 2019;138:104347. doi: 10.1016/j.fitote.2019.104347. - DOI - PubMed
    1. Yu HF, Qin XJ, Ding CF, Wei X, Yang J, Luo JR, Liu L, Khan A, Zhang LC, Xia CF, Luo XD. Org. Lett. 2018;20:4116–4120. doi: 10.1021/acs.orglett.8b01675. - DOI - PubMed

LinkOut - more resources